Phase I Study of HS-20108 in Participants With Advanced Solid Tumors
Status:
NOT_YET_RECRUITING
Trial end date:
2027-11-27
Target enrollment:
Participant gender:
Summary
This is a Phase I clinical study of HS-20108. The purpose of this study is to evaluate the safety, tolerability, PK and efficacy of intravenous HS-20108 in patients with advanced solid tumors.